The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste. Forward-thinking pharma companies are using innovative technologies to build a greener supply chain, which is good for the planet and provides a strategic advantage for the companies.

Environmental Impact and Responsibility

The pharmaceutical industry’s supply chain often produces high emissions and packaging waste. A study by Lotfi Belkhir and Ahmed Elmeligi found that for every $1 million in revenue, the pharmaceutical industry produced 48.55 tons of CO₂ equivalent: 55% more than the automotive industry.

Reducing waste, energy use, and greenhouse gas emissions is crucial for environmental responsibility, and sustainable supply chains are also more resilient to potential disruptions, ensuring patients get their medications without interruption.

Innovative technology solutions

Forward-thinking pharma companies are using technology to create robust, eco-friendly supply chains. Open communication with suppliers, manufacturers, and stakeholders enhances transparency and resilience.

Enhanced supply chain visibility helps companies proactively address regulatory changes and unforeseen challenges. This agility enables quick adaptation to new environmental

regulations and market demands.

Technology plays a crucial role in enhancing sustainability efforts. A recent Deloitte Center for Health Solutions survey of global biopharma supply chain executives found that 24% expect their companies to offer stakeholders real-time insights into their sustainability progress within the next two years. This improved transparency will likely strengthen communication and accountability around these initiatives.

Sustainable practices

Pharma companies partner with vendors and manufacturers committed to sustainability, with a focus on renewable energy, waste reduction, and recycling. For example, developers might prioritize transparency and traceability, while manufacturers might use green chemistry techniques to reduce solvent use. Once the drug is developed, blockchain technology can help create secure records of transactions and processes along the supply chain, ensuring greater accountability.

Empowering with technology

Technology enhances supply chain visibility, helping companies adapt to regulatory changes and challenges. For example, IoT devices can monitor environmental conditions in real time, optimizing energy use and reducing waste. Advanced analytics can predict disruptions, allowing preventive measures.

Examples from the pharma industry

• Pfizer has committed to reducing its greenhouse gas emissions by using renewable energy and improving energy efficiency in its manufacturing processes. They have also implemented green chemistry principles to minimize waste and hazardous substance use.
• Johnson & Johnson has launched a comprehensive sustainability initiative focused on reducing carbon emissions, waste, and water usage across their supply chain. They are also using blockchain technology to enhance transparency and traceability.
• Novartis has integrated sustainability into its core operations by reducing energy consumption and implementing waste reduction programs. They are also investing in advanced analytics to improve supply chain efficiency and predict potential disruptions.
• Roche has adopted energy-efficient manufacturing techniques and sustainable sourcing practices. They use IoT devices to monitor environmental conditions in real time, optimize energy use, and minimize waste.

CDMOs, key players in the pharmaceutical supply chain, are also making significant strides in improving sustainability. They are leveraging innovative approaches and technology to reduce their environmental footprint and create more resilient supply chains. For example, Almac Group engages in sustainable sourcing practices and collaborates with local suppliers to reduce its carbon footprint, and Cayman Chemical implements green chemistry techniques and has invested in solar panels to power its facilities.

These smaller companies are proving that even with limited resources, it is possible to make significant strides towards sustainability. By focusing on innovative solutions and engaging with their communities, they are setting an example for the industry and contributing to a greener future.

Financial and Strategic Benefits

Environmental sustainability is increasingly recognized not only for its ecological benefits but also for its positive financial impacts. According to a McKinsey study, sustainability improvements can affect operating profits by up to 60%. Green chemistry principles and energy-efficient manufacturing techniques reduce operational costs and environmental impact. Reducing waste through lean manufacturing and recycling programs cuts disposal costs and can generate revenue from recycled materials. Efficient resource use minimizes the expenses associated with raw material procurement and waste management. Sustainable companies attract investment and talent, enhancing their competitive edge.

Green solutions benefit the  entire industry

By considering the entire supply chain and applying innovative technologies and sustainability strategies, pharmaceutical companies can mitigate their environmental footprint while ensuring continued access to essential medications. These greener supply chains benefit the environment and provide a strategic and financial advantage. It’s a wise business decision that strengthens the industry for a thriving future.

Elizabeth Hickman serves as chief executive officer at AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates. Elizabeth has over two decades of expertise in the biotech and pharmaceutical sectors, formerly serving in leadership positions for West Pharmaceutical Services, Catalent, and Pii.